CatalYm, a clinical stage biopharma in cancer and cachexia, announced Clinton Musil as its chief financial officer and chief business...
Biopharma
George Eldridge was appointed chief financial officer of Abcuro, a clinical-stage biotech developing therapies for the treatment of autoimmune diseases...
